1 | Autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of HSP70 | - | - | - | - | [1] 46 46 |
2 | Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3) | - | - | - | - | [1] 13 13 |
3 | Cotoretigene Toliparvovec | - | - | - | - | [1] 90 90 |
4 | Diagnostic Test: Candy Glucose Tolerance Test | [1] Dextrose, unspecified form Dextrose, unspecified form (Synonym: 100gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 |
5 | Diagnostic Test: Mixed Meal Tolerance Test | - | - | - | - | [1] 298 298 |
6 | Diagnostic Test: Oral glucose tolerance test | [1] Dextrose, unspecified form Dextrose, unspecified form (Synonym: 100gm Glucose Tolerance Drink) | - | - | - | [3] 13 13, 65, 299 |
7 | Frequently Sampled Oral Glucose Tolerance Test and CGM | [1] Dextrose, unspecified form Dextrose, unspecified form (Synonym: 100gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 |
8 | Glucagon stimulation test and insulin tolerance test | [1] Glucagon Glucagon | [2] D00116
D00116
,
D02118
| [1] GCGR GCGR 💬 | [2] Glucagon signaling pathway Glucagon signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 78 78 |
9 | Home Oral Glucose Tolerance Test kit | [1] Dextrose, unspecified form Dextrose, unspecified form (Synonym: 100gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 |
10 | Itraconazole (Synonym: TOLSURA) | [1] Itraconazole Itraconazole (Synonym: Tolsura) | [1] D00350
D00350
(Name: TOLSURA) | - | - | [5] 3 3, 65, 96, 227, 299 |
11 | Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally. (Synonym: TOLSURA) | [2] Itraconazole Itraconazole (Synonym: Tolsura), Terbinafine (Synonym: Terbinafine HCl Chlortimazole and Tolnaftate) | [3] D00350
D00350
(Name: TOLSURA),
D02219
,
D02375
| - | - | [1] 96 96 |
12 | Itraconazole/voriconazole (Synonym: TOLSURA) | [2] Itraconazole Itraconazole (Synonym: Tolsura), Voriconazole | [2] D00350
D00350
(Name: TOLSURA),
D00578
| - | - | [1] 299 299 |
13 | IV glucose tolerance test | [1] Dextrose, unspecified form Dextrose, unspecified form (Synonym: 100gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 |
14 | Jinarc - Tolvaptan tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
15 | Modified Oral Glucose Tolerance Test (50g 4-hours) | [1] Dextrose, unspecified form Dextrose, unspecified form (Synonym: 100gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 |
16 | OPC-41061 (tolvaptan) | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
17 | Oral Glucose Tolerance Test | [1] Dextrose, unspecified form Dextrose, unspecified form (Synonym: 100gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 |
18 | Oral Glucose Tolerance test (75g 2-hour) | [1] Dextrose, unspecified form Dextrose, unspecified form (Synonym: 100gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 |
19 | Other: Diagnostics for glucose tolerance with 3 different methods. | [1] Dextrose, unspecified form Dextrose, unspecified form (Synonym: 100gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 |
20 | Other: Mixed Meal Tolerance Test | - | - | - | - | [1] 299 299 |
21 | Other: Modified Mixed Meal Tolerance Test | - | - | - | - | [1] 65 65 |
22 | Other: Modified Oral Glucose Tolerance Test | [1] Dextrose, unspecified form Dextrose, unspecified form (Synonym: 100gm Glucose Tolerance Drink) | - | - | - | [1] 65 65 |
23 | Other: Oral Glucose tolerance test | [1] Dextrose, unspecified form Dextrose, unspecified form (Synonym: 100gm Glucose Tolerance Drink) | - | - | - | [3] 160 160, 195, 299 |
24 | Other: Oral Glucose Tolerance Test (OGTT) assessment arm | [1] Dextrose, unspecified form Dextrose, unspecified form (Synonym: 100gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 |
25 | Oxybutynin, tolterodine, solifenacin | [3] Oxybutynin Oxybutynin, Solifenacin, Tolterodine | [6] D00465
D00465
,
D00646
(Name: Tolterodine),
D00722
,
D01148
(Name: Tolterodine tartrate),
D01269
,
D08522
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | [13] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 53 53 |
26 | Phase A Tolvaptan | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
27 | Phase B Tolvaptan | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
28 | TOL | - | - | - | - | [1] 67 67 |
29 | TolaSure Topical Gel | - | - | - | - | [1] 36 36 |
30 | Tolcapon | [1] Tolcapone Tolcapone | [1] D00786
D00786
(Name: Tolcapone) | [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 |
31 | TOLCAPONE | [1] Tolcapone Tolcapone | [1] D00786
D00786
(Name: Tolcapone) | [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [3] 6 6, 28, 127 |
32 | TolDC | - | - | - | - | [1] 46 46 |
33 | Tolebrutinib | - | - | - | - | [2] 11 11, 13 |
34 | Tolebrutinib 120mg | - | - | - | - | [1] 13 13 |
35 | Tolebrutinib 60mg | - | - | - | - | [1] 13 13 |
36 | Tolebrutininb | - | - | - | - | [1] 11 11 |
37 | Tolerogenic dendritic cells | - | - | - | - | [2] 46 46, 96 |
38 | Tolerogenic dendritic cells (tolDC) | - | - | - | - | [1] 13 13 |
39 | Tolerogenic Dendritic cells loaded with myelin peptides | - | - | - | - | [1] 13 13 |
40 | Tolerogenic Fibroblasts | - | - | - | - | [1] 13 13 |
41 | Tolfenamic Acid | [1] Tolfenamic acid Tolfenamic acid | [1] D01183
D01183
(Name: Tolfenamic acid) | [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 5 5 |
42 | Tolicizumab | - | - | - | - | [1] 46 46 |
43 | Tolicizumab Roche | - | - | - | - | [1] 46 46 |
44 | Tolperisone | [1] Tolperisone Tolperisone | [1] D08617
D08617
(Name: Tolperisone) | - | - | [1] 13 13 |
45 | Tolperisone HC1 | [1] Tolperisone Tolperisone | [1] D08617
D08617
(Name: Tolperisone) | - | - | [1] 13 13 |
46 | Tolperisone HCl | [1] Tolperisone Tolperisone | [1] D08617
D08617
(Name: Tolperisone) | - | - | [1] 13 13 |
47 | Tolpersan | - | - | - | - | [1] 13 13 |
48 | Tolposan | - | - | - | - | [1] 13 13 |
49 | Tolterodine | [1] Tolterodine Tolterodine | [2] D00646
D00646
(Name: Tolterodine),
D01148
(Name: Tolterodine tartrate) | [1] CHRM3 CHRM3 💬 | [11] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [2] 17 17, 53 |
50 | Tolubuterol Hydrochloride | - | - | - | - | [1] 6 6 |
51 | TOLVAPTAN | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [3] 67 67, 72, 225 |
52 | TOLVAPTAN (OPC-41061) | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
53 | Tolvaptan (SAMSCA) | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 72 72 |
54 | TOLVAPTAN 15 | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
55 | Tolvaptan 15 mg Tablet | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
56 | Tolvaptan 15 mg tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
57 | Tolvaptan 15mg | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
58 | TOLVAPTAN 30 | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
59 | Tolvaptan 30 mg Tablet | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
60 | Tolvaptan 30 mg tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
61 | Tolvaptan 30mg | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
62 | TOLVAPTAN 45/15 | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
63 | Tolvaptan 50mg Granules | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
64 | TOLVAPTAN 60/30 | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
65 | Tolvaptan 7.5 mg Tablet | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
66 | Tolvaptan in euvolemic hyponatremia | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 72 72 |
67 | Tolvaptan IR | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
68 | Tolvaptan MR | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
69 | Tolvaptan Oral Tablet | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 72 72 |
70 | Tolvaptan Suspension | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
71 | Tolvaptan Tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
(Name: Tolvaptan) | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |